Prognostic value of molecular classification in stage IV endometrial cancer.
Margot H UijterwaalDionne van DijkChristianne A R LokCor D De KroonJenneke C KasiusRonald ZweemerCornelis G GeresteinNanda HorewegTjalling BosseJacolien van der MarelLinda S NooijPublished in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2024)
The distribution of the molecular subclasses in stage IV endometrial cancer patients differed substantially from the distribution in stage I-III endometrial cancer patients, with the unfavorable subclasses being more frequently present. Although the molecular classification was not prognostic in stage IV endometrial cancer, it could guide adjuvant treatment decisions.